EX-32.1 4 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATIONS PURSUANT TO

18 U.S.C. SECTION 1350,

AS ENACTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Biostar Angel Stem Cell Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Keewon Ra, Chief Executive Officer and Corporate Secretary of the Company, and Won Ho Chun, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

November 16, 2018 /s/ Keewon Ra
  Keewon Ra
  Chief Executive Officer and Corporate Secretary
  (Principal Executive Officer)
   
November 16, 2018 /s/ Won Ho Chun
  Won Ho Chun
  Chief Financial Officer
  (Principal Financial Officer)